CYP2A13 Antikörper (C-Term)
Kurzübersicht für CYP2A13 Antikörper (C-Term) (ABIN630443)
Target
Alle CYP2A13 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- CYP2 A13 antibody was raised against the C terminal of CYP2 13
-
Aufreinigung
- Purified
-
Immunogen
- CYP2 A13 antibody was raised using the C terminal of CYP2 13 corresponding to a region with amino acids DPRFFSNPRDFNPQHFLDKKGQFKKSDAFVPFSIGKRYCFGEGLARMELF
-
-
-
-
Applikationshinweise
-
WB: 5 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
CYP2A13 Blocking Peptide, (ABIN937498), is also available for use as a blocking control in assays to test for specificity of this CYP2A13 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of CYP0 13 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- CYP2A13 (Cytochrome P450, Family 2, Subfamily A, Polypeptide 13 (CYP2A13))
-
Andere Bezeichnung
- CYP2A13
-
Hintergrund
- CYP2A13 is a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. Although its endogenous substrate has not been determined, it is known to metabolize 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a major nitrosamine specific to tobacco.
-
Molekulargewicht
- 54 kDa (MW of target protein)
Target
-